About Dexcom Inc

DexCom, Inc. empowers people to take control of diabetes through innovative continuous glucose monitoring (CGM) products. Headquartered in San Diego, California, Dexcom has emerged as a leader of diabetes care technology. By listening to the needs of patients, caregivers, and clinicians, Dexcom simplifies and improves diabetes management around the world.

CEO

Kevin Sayer

Employees

5500

Headquarters

6340 Sequence Dr
San Diego, California 92121-4356
Phone: 18582000200
www.dexcom.com

News

SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of DexCom
Aug 30, 2024 14:31pm

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In DexCom To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $100,000 in DexCom between January 8, 2024 to July 25, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or Jetzt den vollständigen Artikel lesen

Source:Wallstreet:Online

DXCM LEGAL UPDATE: Suffer Losses on Your DexCom, Inc. Investment? Contact BFA Law about the Class Action Lawsuit for Securities Fraud (Nasdaq:DXCM)
Aug 30, 2024 10:39am

DexCom, Inc. investors that lost money on their investment are encouraged to contact BFA Law before October 21, 2024 legal deadline.

Source:GlobeNewswire

DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of DexCom
Aug 30, 2024 00:43am

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In DexCom To Contact Him Directly To Discuss Their Options

Source:GlobeNewswire

DXCM LEGAL ALERT: BFA Law Alerts DexCom, Inc. Investors that Lost Money on their Investment to Contact the Firm about the Securities Fraud Class Action Lawsuit
Aug 29, 2024 11:12am

New York, New York--(Newsfile Corp. - August 29, 2024) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against DexCom, Inc. (NASDAQ: DXCM) and certain of the Company''s senior executives. If you invested in DexCom, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/dexcom-inc. Investors Jetzt den vollständigen Artikel lesen

Source:Wallstreet:Online

Class Action Filed Against DexCom, Inc. (DXCM) - October 21, 2024 Deadline to Join - Contact The Gross Law Firm
Aug 29, 2024 09:45am

NEW YORK, Aug. 29, 2024 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of DexCom, Inc. (NASDAQ: DXCM). Shareholders who purchased shares of DXCM during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment….

Source:PR Newswire

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages DexCom, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - DXCM
Aug 29, 2024 00:14am

New York, New York--(Newsfile Corp. - August 28, 2024) - WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of all purchasers of securities of DexCom, Inc. (NASDAQ: DXCM) between January 8, 2024 and July 25, 2024, both dates inclusive (the "Class Period"). A class action has already been filed. If you wish to serve as lead plaintiff, Jetzt den vollständigen Artikel lesen

Source:Wallstreet:Online

Contact Levi & Korsinsky by October 21, 2024 Deadline to Join Class Action Against DexCom, Inc. (DXCM)
Aug 28, 2024 16:40pm

NEW YORK, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in DexCom, Inc. ("DexCom" or the "Company") (NASDAQ: DXCM) of a class action securities lawsuit.

Source:GlobeNewswire

Dexcom Announces Upcoming Conference Presentation
Aug 28, 2024 12:30pm

DexCom, Inc. (NASDAQ:DXCM) today announced that Kevin Sayer, Chairman, President and Chief Executive Officer, and Jereme Sylvain, Executive Vice President and Chief Financial Officer, will present an update on the company at the 2024 Wells Fargo Healthcare Conference on Wednesday, September 4th. The live presentation is scheduled to begin at approximately 11:00 AM EST and will be concurrently Jetzt den vollständigen Artikel lesen

Source:Wallstreet:Online

DXCM Investor Alert: Contact Kessler Topaz Meltzer & Check, LLP About the Securities Fraud Class Action Lawsuit Filed Against Dexcom, Inc. (DXCM)
Aug 28, 2024 00:11am

Radnor, Pennsylvania--(Newsfile Corp. - August 27, 2024) - The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Southern District of California against DexCom, Inc. ("DexCom") (NASDAQ: DXCM) on behalf of investors who purchased or otherwise acquired DexCom securities between Jetzt den vollständigen Artikel lesen

Source:Wallstreet:Online

Poulin | Willey | Anastopoulo Notifies DexCom, Inc., Investors of the Pending Class Action Lawsuit
Aug 27, 2024 19:51pm

Poulin | Willey | Anastopoulo announces class action lawsuit in the SDCA on behalf of purchasers of NASDAQ:DXCM between January 8 and July 25, 2024. CHARLESTON, SOUTH CAROLINA, UNITED STATES, August 27, 2024 /⁨EINPresswire.com⁩/ -- Charleston, …

Source:EIN News IT